BioCardia's market cap is currently $11.09M. The company's EPS TTM is $-4.157; its P/E ratio is ―; BioCardia is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 477.00K	$ 1.35M	$ 1.01M	$ 145.00K	$ 710.00K
Gross Profit	$ -7.25M	$ -10.55M	$ 375.00K	$ 141.00K	$ 352.00K
Operating Income	$ -11.64M	$ -11.90M	$ -12.63M	$ -15.53M	$ -14.21M
EBITDA	$ -11.56M	$ -11.82M	$ -12.57M	$ -14.44M	$ -14.05M
Net Income	$ -11.57M	$ -11.91M	$ -12.62M	$ -15.01M	$ -14.82M
Balance Sheet
Cash & Short-Term Investments	$ 1.10M	$ 7.36M	$ 12.87M	$ 21.41M	$ 5.58M
Total Assets	$ 2.99M	$ 9.79M	$ 15.72M	$ 23.42M	$ 7.68M
Total Debt	$ 1.31M	$ 1.63M	$ 1.87M	$ 614.00K	$ 1.14M
Net Debt	$ 212.00K	$ -5.73M	$ -11.00M	$ -20.79M	$ -4.44M
Total Liabilities	$ 4.59M	$ 4.90M	$ 5.34M	$ 4.25M	$ 5.31M
Stockholders' Equity	$ -1.60M	$ 4.89M	$ 10.38M	$ 19.18M	$ 2.37M
Cash Flow
Free Cash Flow	$ -9.99M	$ -10.63M	$ -10.48M	$ -12.39M	$ -9.59M
Operating Cash Flow	$ -9.97M	$ -10.56M	$ -10.37M	$ -12.36M	$ -9.45M
Investing Cash Flow	$ -12.00K	$ -70.00K	$ -116.00K	$ -32.00K	$ -146.00K
Financing Cash Flow	$ 3.73M	$ 5.12M	$ 1.95M	$ 28.21M	$ 9.82M

Currency in USD

BioCardia Earnings and Revenue History

Income Statement >

BioCardia Debt to Assets

Balance Sheet >

BioCardia Cash Flow

Cash Flow >

BioCardia Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing